Making Every Component Count: Using the Shapley Value To Improve Win Ratio Analysis
Overview
Clinical trials often utilize composite endpoints to provide a comprehensive evaluation of a treatment’s effects by combining multiple related outcomes into a single measure. While traditional methods, such as time-to-first-event analysis, are widely used, they face limitations, including equal weighting of components, disproportionate influence of non-fatal events, and neglect of recurrent outcomes. The win ratio has emerged as an alternative, prioritizing outcomes by clinical importance and offering greater flexibility. However, it provides limited insight into the contributions of individual components to the overall treatment effect. To address this gap, we develop the SEWRA (Shapley-Enhanced Win Ratio Analysis) algorithm, which integrates the Shapley value, a concept from cooperative game theory, into win ratio analysis. SEWRA fairly allocates the total treatment effect across the components of a composite endpoint, reflecting their relative contributions within the context of the overall win ratio. This approach enhances the interpretability of the win ratio and provides a deeper understanding of the treatment’s impact on individual outcomes. Through simulations and case studies, we demonstrate how SEWRA offers a nuanced framework for analyzing composite endpoints, complementing existing methodologies and addressing their limitations. Our work aims to advance the analytical tools available for clinical trial data, promoting more informed decision-making and improved patient outcomes.
Competition history
- ISEF 2025
Resources
Related projects
JSHS · 2025
Experience-based neural tradeoffs in perceptual sampling vs. predictive processing in the visual domain
ISEF · 2016
Predictive Modeling of Optimal Cancer Therapies
ISEF · 2026
From SMILES to Synergy: Biologically-Enriched Drug Screening for Synergistic Combination Therapy in Tamoxifen Resistant ER+ Breast Cancer
ISEF · 2014
Rational Discovery and Optimization of Synergistic Chemotherapy Combinations: A Novel Framework Integrating Gene Perturbation Analysis and Machine Learning Algorithms
ISEF · 2016
Genomics-Based Cancer Drug Response Prediction through the Adaptive Elastic Net
ISEF · 2015
A Novel Computational Method for Subdividing Hepatocellular Carcinoma Patients into Uniquely Treatable Clusters
JSHS · 2020
Identifying Optimal Panobinostat Treatment Regimens Utilizing Reverse-Engineered Concentration-Time Curves
ISEF · 2024
Predicting Optimal Combinations of Regulatory Transcription Factor Perturbations to Simulate Complex Cell-State Conversion Paths Using Combinatorial Optimization and Machine Learning
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair